Table 3.
Adjusted R2 | F | Standardized β | Effect Size (Cohen’s d) | p | |
---|---|---|---|---|---|
Daily Function | 0.16 | 3.99 | 0.003* | ||
CR statusa | 0.04* | ||||
(HA) | 0.25 | 0.86 | 0.07 | ||
(HCV High CR) | 0.33 | 0.95 | 0.01* | ||
Genderb (female) | 0.04 | 0.69 | |||
BDI | −0.28 | 0.01* | |||
LT SUD historyc | −0.07 | 0.56 | |||
| |||||
BRIEF-A | 0.47 | 14.50 | <0.001* | ||
CR statusa | 0.63 | ||||
(HA) | 0.11 | 0.32 | 0.35 | ||
(HCV High CR) | 0.04 | 0.12 | 0.72 | ||
Genderb (female) | −0.02 | 0.82 | |||
BDI | 0.63 | <0.001* | |||
LT SUD historyc | 0.24 | 0.01* |
Note: CR = cognitive reserve, HA = healthy adults, BDI-II = Beck Depression Inventory-II, LT SUD = Lifetime substance use disorders.
HCV Low CR group is the reference.
Male is the reference.
Presence of LT SUD history is the reference.